IDSA GUIDELINES Bundle (free trial)

Skin and Soft Tissue Infections

IDSA GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/442091

Contents of this Issue

Navigation

Page 9 of 25

8 Treatment Pyomyositis Î Magnetic resonance imaging (MRI) is the recommended imaging modality for establishing the diagnosis of pyomyositis. Computed tomography (CT) scan and ultrasound studies are also useful (SR-M). Î Cultures of blood and abscess material should be obtained (SR-M). Î Vancomycin is recommended for initial empiric therapy. An agent active against enteric Gram-negative bacilli should be added for infection in immunocompromised patients or after open trauma to the muscles (SR-M). Î Cefazolin or antistaphylococcal penicillin (eg, nafcillin or oxacillin) is recommended for treatment of pyomyositis caused by MSSA (SR-M). Î Early drainage of purulent material should be performed (SR-H). Î Repeat imaging studies should be performed in patients with persistent bacteremia to identify undrained foci of infection (SR-L). Î Antibiotics should be administered intravenously initially, but once the patient is clinically improved oral antibiotics are appropriate for patients in whom bacteremia cleared promptly and there is no evidence of endocarditis or metastatic abscess. Two to three weeks of therapy is recommended (SR-L). Clostridial Gas Gangrene or Myonecrosis Î Urgent surgical exploration of the suspected gas gangrene site and surgical debridement of involved tissue should be performed (See Fig. 1/Nonpurulent/SEVERE) (SR-M). Î In the absence of a definitive etiologic diagnosis, broad-spectrum treatment with vancomycin plus either piperacillin/tazobactam, ampicillin/sulbactam or a carbapenem antimicrobial is recommended (SR-L). Definitive antimicrobial therapy with penicillin and clindamycin is recommended for treatment of clostridial myonecrosis (SR-L). Î Hyperbaric oxygen (HBO) therapy is NOT recommended because it has not been proven as a benefit to patients and may delay resuscitation and surgical debridement (SR-L).

Articles in this issue

Archives of this issue

view archives of IDSA GUIDELINES Bundle (free trial) - Skin and Soft Tissue Infections